Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS Framework Agreement for the supply of Recombinant Factor IX products for the treatment of Haemophilia B

NHS England

This public procurement record has 7 releases in its history.

AwardUpdate

25 Mar 2019 at 16:04

Award Notice
Award

12 Mar 2019 at 16:53

Award Notice
TenderAmendment

12 Mar 2019 at 16:36

Tender Notice
TenderAmendment

20 Nov 2018 at 11:55

Tender Notice
TenderAmendment

20 Nov 2018 at 10:44

Tender Notice
TenderAmendment

16 Nov 2018 at 17:26

Tender Notice
Tender

07 Nov 2018 at 14:51

Tender Notice
Summary of the contracting process

NHS England is seeking suppliers for a Framework Agreement concerning the supply of Recombinant Factor IX products for treating Haemophilia B. This procurement falls under the goods category, specifically classified as blood coagulants (CPV code: 33141530). The framework commenced on 1st March 2019 and will run for 24 months, concluding on 28th February 2021, with potential extensions of up to an additional 24 months. The total estimated value of this contract is £192 million. The tender was published on 7th November 2018, with the tender period set to close on 11th December 2018.

This procurement presents substantial opportunities for businesses, particularly small and medium-sized enterprises (SMEs) involved in medical supplies and pharmaceuticals. Companies that have expertise in supplying blood coagulants or related medical products would be well-suited to compete in this tender. Collaborating or forming partnerships with larger suppliers may further enhance the chances for SMEs to successfully participate in this framework and expand their market reach.

How relevant is this notice?

Notice Information

Notice Title

NHS Framework Agreement for the supply of Recombinant Factor IX products for the treatment of Haemophilia B

Notice Description

NHS National Framework Agreement for the supply of Recombinant Factor IX products for the treatment of Haemophilia B. The framework will commence on 1st March 2019 for a period of 24 months until 28th February 2021, with options to extend up to a further 24 month.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-e9aa86d5-034f-4ac0-957f-a4479ae257f5
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/4b4175f9-e4ff-4ca9-a23b-79d639ae18c9
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure (above threshold)
Tender Suitability
SME
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33141530 - Blood coagulants

Notice Value(s)

Tender Value
£192,000,000 £100M-£1B
Lots Value
Not specified
Awards Value
£192,000,000 £100M-£1B
Contracts Value
Not specified

Notice Dates

Publication Date
25 Mar 20197 years ago
Submission Deadline
11 Dec 2018Expired
Future Notice Date
Not specified
Award Date
15 Feb 20197 years ago
Contract Period
1 Mar 2019 - 28 Feb 2021 2-3 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
RUNCORN
Postcode
WA7 2ES
Postcode Area
Warrington
Country
England
Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD7 Merseyside
Small Region (ITL 3)
TLD71 East Merseyside
Delivery Location
TLL Wales, TLM Scotland, TLN Northern Ireland
Local Authority
Halton
Electoral Ward
Halton Lea
Westminster Constituency
Runcorn and Helsby

Supplier Information

Number of Suppliers
5
Supplier Names

CSL Behring UK Limited

Novo Nordisk Ltd

Pfizer Ltd

Shire Pharmaceuticals Ltd

Swedish Orphan Biovitrum Ltd (Sobi UK Ltd)

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...